Financial News

Financial Report: Sanofi

Lantus sales slide, driving down diabetes revenues

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi   3Q Revenues: €9.6 billion (+3%) 3Q Earnings: €2.1 billion  (+5%) YTD Revenues: €27.8 billion (+4%) YTD Earnings: €5.7 billion (+4%) Comments: Pharmaceutical sales were €7.3 billion (+3%). Diabetes sales were €1.9 billion, down 7%, as a result of lower U.S. sales of Lantus (worldwide sales -11% to €1.6 billion). Genzyme sales were €923 million in the quarter, up 33%, with strong momentum driven by Multiple Sclerosis products and Aubagio sales up 79% to €225 million. Vaccine...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters